|Articles|August 3, 2000

Guidelines for Reuse of Medical Devices

FDA to Increase Regulation of Hospitals and Reprocessing Companies

Because of the increased practice of reusing medical devices, the Food and Drug Administration is taking steps to more rigorously regulate the practice. A recent report by the General Accounting Office estimated that 20% to 30% of U.S. hospitals reuse devices such as surgical saw blades, drills, catheters, and forceps in order to cut the cost of the devices. While the devices are cleaned, sterilized and repackaged, there have been a number of reports of patients being harmed by such devices. Under the new guidelines, hospitals that reuse devices and the independent companies that sterilize and repackage them will be regulated in the same manner as the device makers. This will mean that hospitals and reprocessing companies will now have to submit information to the FDA indicating the safety and effectiveness of a device used more than once. Additional rules also call for the registration of businesses that reuse or reprocess medical devices as well as the submission of "adverse event reports." While the new guidelines only apply to hospitals, the FDA said that they might later be applied to all healthcare facilities. For more information and the latest updates, visit the Food and Drug Administration web site at www.fda.gov.


Related to this article

Water  (Adobe Stock 456102510 by stockphoto-graf)
Understanding current water quality is a starting point for ST108 implementation. John Kimsey, vice president of processing optimization and customer success for STERISS, spoke about his HSPA presentation on assessing readiness, distinguishing system qualification from routine testing, and understanding where water samples should be collected.
Image of Pathogens flying   (Adobe Stock weerasak)
Behind every landmark in infection prevention, from antimicrobial stewardship guidelines to the COVID-19 town halls that reached flight attendants and teachers, is a generation of physician-scientists who led SHEA through crises, organizational change, and scientific breakthroughs. Infection Control Today traces 30 years of SHEA presidents and the lasting mark they left on the field.
AORN26 New Orleans 2026  (Adobe Stock)
Missing instruments and processing delays can strain OR–SPD relationships. At AORN 2026, John Kimsey, vice president of processing optimization and customer success for STERIS, discusses understanding root causes, exploring off-site reprocessing for ambulatory surgical centers, and using hands-on simulation to help surgical teams see sterile processing from a different perspective.